Intrinsic deletion at 10q23.31, including the PTEN gene locus, is aggravated upon CRISPR-Cas9–mediated genome engineering in HAP1 cells mimicking cancer profiles
Life Science Alliance · 2024
DOI: 10.26508/lsa.202302128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2024. Verfasst von Keyi Geng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Tumor, and Cell Biology, Science for Life Laboratory, Karolinska Institute, Solna, Sweden. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Scholarship Council, EMBO Postdoctoral Fellowship, Knut och Alice Wallenbergs Stiftelse.
Abstract (Originalsprache)
The CRISPR-Cas9 system is a powerful tool for studying gene functions and holds potential for disease treatment. However, precise genome editing requires thorough assessments to minimize unintended on- and off-target effects. Here, we report an unexpected 283-kb deletion on Chromosome 10 (10q23.31) in chronic myelogenous leukemia-derived HAP1 cells, which are frequently used in CRISPR screens. The deleted region encodes regulatory genes, including PAPSS2 , ATAD1 , KLLN , and PTEN . We found that this deletion was not a direct consequence of CRISPR-Cas9 off-targeting but rather occurred frequently during the generation of CRISPR-Cas9–modified cells. The deletion was associated with global changes in histone acetylation and gene expression, affecting fundamental cellular processes such as cell cycle and DNA replication. We detected this deletion in cancer patient genomes. As in HAP1 cells, the deletion contributed to similar gene expression patterns among cancer patients despite interindividual differences. Our findings suggest that the unintended deletion of 10q23.31 can confound CRISPR-Cas9 studies and underscore the importance to assess unintended genomic changes in CRISPR-Cas9–modified cells, which could impact cancer research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Tumor, and Cell Biology, Science for Life Laboratory, Karolinska Institute, Solna, Sweden.
- Department of Microbiology, Tumor, and Cell Biology, Science for Life Laboratory, Karolinska Institute, Solna, Sweden claudia.kutter@ki.se.
ORCID-Profile: Keyi Geng, Lara G Merino, Raül G Veiga, Christian Sommerauer, Janine Epperlein, Eva K Brinkman, Claudia Kutter
Förderung
- Chinese Scholarship Council
- EMBO Postdoctoral Fellowship
- Knut och Alice Wallenbergs Stiftelse
- Ruth och Richard Julins Stiftelse
- SFO SciLifeLab fellowship
- Karolinska Institutet - KID
- Vetenskapsrådet
- Lillian Sagen & Curt Ericsson Research Foundation
Zitieren
APA
Geng, K., Merino, L. G., Veiga, R. G., Sommerauer, C., Epperlein, J., Brinkman, E. K., & Kutter, C. (2024). Intrinsic deletion at 10q23.31, including the PTEN gene locus, is aggravated upon CRISPR-Cas9–mediated genome engineering in HAP1 cells mimicking cancer profiles. Life Science Alliance. https://doi.org/10.26508/lsa.202302128
Vancouver
Geng K, Merino LG, Veiga RG, Sommerauer C, Epperlein J, Brinkman EK, et al. Intrinsic deletion at 10q23.31, including the PTEN gene locus, is aggravated upon CRISPR-Cas9–mediated genome engineering in HAP1 cells mimicking cancer profiles. Life Science Alliance. 2024. doi:10.26508/lsa.202302128
BibTeX
@article{Geng2024,
author = {Geng, Keyi and Merino, Lara G and Veiga, Raül G and Sommerauer, Christian and Epperlein, Janine and Brinkman, Eva K and Kutter, Claudia},
title = {Intrinsic deletion at 10q23.31, including the PTEN gene locus, is aggravated upon CRISPR-Cas9–mediated genome engineering in HAP1 cells mimicking cancer profiles},
journal = {Life Science Alliance},
year = {2024},
doi = {10.26508/lsa.202302128}
}
EUVIMED